Fig. 1From: Predictive value of delta radiomics in xerostomia after chemoradiotherapy in patients with stage III-IV nasopharyngeal carcinomaCase screening process. A total of 255 eligible cases were screened, including 92 patients with mild and 163 patients with severe xerostomiaBack to article page